
Helicobacter Pylori Infection Treatment - Global and China Top Players Market Share and Ranking 2023
Helicobacter Pylori Infection Treatment Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for Helicobacter Pylori Infection Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Helicobacter Pylori Infection Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Helicobacter Pylori Infection Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Diagnostics Laboratories grew percent.
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
This report studies and analyses global Helicobacter Pylori Infection Treatment status and future trends, to help determine the Helicobacter Pylori Infection Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Helicobacter Pylori Infection Treatment, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Helicobacter Pylori Infection Treatment market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Helicobacter Pylori Infection Treatment by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Helicobacter Pylori Infection Treatment by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Helicobacter Pylori Infection Treatment key consuming regions, consumption value and demand structure
(5) Helicobacter Pylori Infection Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Cumberland Pharmaceuticals
Eisai Co.
Bio-Rad Laboratories
F. Hoffmann-La Roche
Alpha Laboratories
Biohit
Phathom Pharmaceuticals
Redhill Biopharma
Takeda Pharmaceuticals
AbbVie
Market segment by Type, covers
Bismuth-quadruple Therapy
Concomitant Therapy
Levofloxacin Triple Therapy
Bismuth Therapy
High-dose Dual Therapy
Market segment by Application, can be divided into
Hospitals
Diagnostics Laboratories
Clinics
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Helicobacter Pylori Infection Treatment product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Helicobacter Pylori Infection Treatment market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Helicobacter Pylori Infection Treatment market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Helicobacter Pylori Infection Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Helicobacter Pylori Infection Treatment Definition
1.2 Global Helicobacter Pylori Infection Treatment Market Size and Forecast
1.3 China Helicobacter Pylori Infection Treatment Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Helicobacter Pylori Infection Treatment Market Size: China VS Global Growth Rate, 2018-2029
1.6 Helicobacter Pylori Infection Treatment Market Dynamics
1.6.1 Helicobacter Pylori Infection Treatment Market Drivers
1.6.2 Helicobacter Pylori Infection Treatment Market Restraints
1.6.3 Helicobacter Pylori Infection Treatment Industry Trends
1.6.4 Helicobacter Pylori Infection Treatment Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Helicobacter Pylori Infection Treatment, Global Market Share by Company, 2018-2023
2.2 Global Helicobacter Pylori Infection Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Helicobacter Pylori Infection Treatment Concentration Ratio
2.4 Global Helicobacter Pylori Infection Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Helicobacter Pylori Infection Treatment Major Companies Product Type
2.6 Head Office and Helicobacter Pylori Infection Treatment Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Helicobacter Pylori Infection Treatment, China Market Share by Company, 2018-2023
3.2 China Helicobacter Pylori Infection Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Helicobacter Pylori Infection Treatment Industry Chain
4.2 Helicobacter Pylori Infection Treatment Upstream Analysis
4.2.1 Helicobacter Pylori Infection Treatment Core Raw Materials
4.2.2 Main Manufacturers of Helicobacter Pylori Infection Treatment Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Helicobacter Pylori Infection Treatment Production Mode
4.6 Helicobacter Pylori Infection Treatment Procurement Model
4.7 Helicobacter Pylori Infection Treatment Industry Sales Model and Sales Channels
4.7.1 Helicobacter Pylori Infection Treatment Sales Model
4.7.2 Helicobacter Pylori Infection Treatment Typical Distributors
5 Sights by Type
5.1 Helicobacter Pylori Infection Treatment Classification
5.1.1 Bismuth-quadruple Therapy
5.1.2 Concomitant Therapy
5.1.3 Levofloxacin Triple Therapy
5.1.4 Bismuth Therapy
5.1.5 High-dose Dual Therapy
5.2 By Type, Global Helicobacter Pylori Infection Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029
6 Sights by Application
6.1 Helicobacter Pylori Infection Treatment Segment by Application
6.1.1 Hospitals
6.1.2 Diagnostics Laboratories
6.1.3 Clinics
6.2 By Application, Global Helicobacter Pylori Infection Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Helicobacter Pylori Infection Treatment & Forecasts, 2018-2029
7.3.2 By Country, North America Helicobacter Pylori Infection Treatment Market Size Market Share
7.4 Europe
7.4.1 Europe Helicobacter Pylori Infection Treatment Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Helicobacter Pylori Infection Treatment Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Helicobacter Pylori Infection Treatment Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Helicobacter Pylori Infection Treatment Market Size Market Share
7.6 South America
7.6.1 South America Helicobacter Pylori Infection Treatment Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Helicobacter Pylori Infection Treatment Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Helicobacter Pylori Infection Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.3.2 By Type, U.S. Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.4.2 By Type, Europe Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.5.2 By Type, China Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.6.2 By Type, Japan Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.7.2 By Type, South Korea Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.9.2 By Type, India Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Cumberland Pharmaceuticals
9.1.1 Cumberland Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.1.2 Cumberland Pharmaceuticals Company Profile and Main Business
9.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.1.4 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.1.5 Cumberland Pharmaceuticals Recent Developments
9.2 Eisai Co.
9.2.1 Eisai Co. Company Information, Head Office, Market Area and Industry Position
9.2.2 Eisai Co. Company Profile and Main Business
9.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.2.4 Eisai Co. Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.2.5 Eisai Co. Recent Developments
9.3 Bio-Rad Laboratories
9.3.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
9.3.2 Bio-Rad Laboratories Company Profile and Main Business
9.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.3.4 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.3.5 Bio-Rad Laboratories Recent Developments
9.4 F. Hoffmann-La Roche
9.4.1 F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
9.4.2 F. Hoffmann-La Roche Company Profile and Main Business
9.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.4.4 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.4.5 F. Hoffmann-La Roche Recent Developments
9.5 Alpha Laboratories
9.5.1 Alpha Laboratories Company Information, Head Office, Market Area and Industry Position
9.5.2 Alpha Laboratories Company Profile and Main Business
9.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.5.4 Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.5.5 Alpha Laboratories Recent Developments
9.6 Biohit
9.6.1 Biohit Company Information, Head Office, Market Area and Industry Position
9.6.2 Biohit Company Profile and Main Business
9.6.3 Biohit Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.6.4 Biohit Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.6.5 Biohit Recent Developments
9.7 Phathom Pharmaceuticals
9.7.1 Phathom Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.7.2 Phathom Pharmaceuticals Company Profile and Main Business
9.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.7.4 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.7.5 Phathom Pharmaceuticals Recent Developments
9.8 Redhill Biopharma
9.8.1 Redhill Biopharma Company Information, Head Office, Market Area and Industry Position
9.8.2 Redhill Biopharma Company Profile and Main Business
9.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.8.4 Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.8.5 Redhill Biopharma Recent Developments
9.9 Takeda Pharmaceuticals
9.9.1 Takeda Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.9.2 Takeda Pharmaceuticals Company Profile and Main Business
9.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.9.4 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.9.5 Takeda Pharmaceuticals Recent Developments
9.10 AbbVie
9.10.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.10.2 AbbVie Company Profile and Main Business
9.10.3 AbbVie Helicobacter Pylori Infection Treatment Models, Specifications and Application
9.10.4 AbbVie Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023
9.10.5 AbbVie Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Helicobacter Pylori Infection Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Helicobacter Pylori Infection Treatment Market Restraints
Table 3. Helicobacter Pylori Infection Treatment Market Trends
Table 4. Helicobacter Pylori Infection Treatment Industry Policy
Table 5. Global Helicobacter Pylori Infection Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Helicobacter Pylori Infection Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Helicobacter Pylori Infection Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Helicobacter Pylori Infection Treatment Mergers & Acquisitions, Expansion Plans
Table 9. Global Helicobacter Pylori Infection Treatment Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Helicobacter Pylori Infection Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Helicobacter Pylori Infection Treatment Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Helicobacter Pylori Infection Treatment Upstream (Raw Materials)
Table 14. Global Helicobacter Pylori Infection Treatment Typical Customers
Table 15. Helicobacter Pylori Infection Treatment Typical Distributors
Table 16. By Type, Global Helicobacter Pylori Infection Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Helicobacter Pylori Infection Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Helicobacter Pylori Infection Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2018-2029
Table 23. Cumberland Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 24. Cumberland Pharmaceuticals Company Profile and Main Business
Table 25. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 26. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Cumberland Pharmaceuticals Recent Developments
Table 28. Eisai Co. Company Information, Head Office, Market Area and Industry Position
Table 29. Eisai Co. Company Profile and Main Business
Table 30. Eisai Co. Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 31. Eisai Co. Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Eisai Co. Recent Developments
Table 33. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
Table 34. Bio-Rad Laboratories Company Profile and Main Business
Table 35. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 36. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Bio-Rad Laboratories Recent Developments
Table 38. F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
Table 39. F. Hoffmann-La Roche Company Profile and Main Business
Table 40. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 41. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. F. Hoffmann-La Roche Recent Developments
Table 43. Alpha Laboratories Company Information, Head Office, Market Area and Industry Position
Table 44. Alpha Laboratories Company Profile and Main Business
Table 45. Alpha Laboratories Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 46. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Alpha Laboratories Recent Developments
Table 48. Biohit Company Information, Head Office, Market Area and Industry Position
Table 49. Biohit Company Profile and Main Business
Table 50. Biohit Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 51. Biohit Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Biohit Recent Developments
Table 53. Phathom Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 54. Phathom Pharmaceuticals Company Profile and Main Business
Table 55. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 56. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Phathom Pharmaceuticals Recent Developments
Table 58. Redhill Biopharma Company Information, Head Office, Market Area and Industry Position
Table 59. Redhill Biopharma Company Profile and Main Business
Table 60. Redhill Biopharma Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 61. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Redhill Biopharma Recent Developments
Table 63. Takeda Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 64. Takeda Pharmaceuticals Company Profile and Main Business
Table 65. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 66. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Takeda Pharmaceuticals Recent Developments
Table 68. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 69. AbbVie Company Profile and Main Business
Table 70. AbbVie Helicobacter Pylori Infection Treatment Models, Specifications, and Application
Table 71. AbbVie Helicobacter Pylori Infection Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. AbbVie Recent Developments
List of Figures
Figure 1. Helicobacter Pylori Infection Treatment Picture
Figure 2. Global Helicobacter Pylori Infection Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Helicobacter Pylori Infection Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Helicobacter Pylori Infection Treatment Market Share of Global, 2018-2029
Figure 5. Global Helicobacter Pylori Infection Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Helicobacter Pylori Infection Treatment Key Participants, Market Share, 2022
Figure 7. Helicobacter Pylori Infection Treatment Industry Chain
Figure 8. Helicobacter Pylori Infection Treatment Procurement Model
Figure 9. Helicobacter Pylori Infection Treatment Sales Model
Figure 10. Helicobacter Pylori Infection Treatment Sales Channels, Direct Sales, and Distribution
Figure 11. Bismuth-quadruple Therapy
Figure 12. Concomitant Therapy
Figure 13. Levofloxacin Triple Therapy
Figure 14. Bismuth Therapy
Figure 15. High-dose Dual Therapy
Figure 16. By Type, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 17. By Type, Global Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2018-2029
Figure 18. Hospitals
Figure 19. Diagnostics Laboratories
Figure 20. Clinics
Figure 21. By Application, Global Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 22. By Application, Global Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2018-2029
Figure 23. By Region, Global Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2018-2029
Figure 24. North America Helicobacter Pylori Infection Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, North America Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022
Figure 26. Europe Helicobacter Pylori Infection Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, Europe Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022
Figure 28. Asia Pacific Helicobacter Pylori Infection Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country/Region, Asia Pacific Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022
Figure 30. South America Helicobacter Pylori Infection Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, South America Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022
Figure 32. Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. U.S. Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, U.S. Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 36. Europe Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, Europe Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, Europe Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 39. China Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, China Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, China Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 42. Japan Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, Japan Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, Japan Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 45. South Korea Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, South Korea Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 48. Southeast Asia Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, Southeast Asia Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, Southeast Asia Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 51. India Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, India Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, India Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 54. Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value, 2018-2029, US$ Million
Figure 55. By Type, Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 56. By Application, Middle East & Africa Helicobacter Pylori Infection Treatment Consumption Value Market Share, 2022 VS 2029
Figure 57. Research Methodology
Figure 58. Breakdown of Primary Interviews
Figure 59. Bottom-up and Top-down Approaches
Figure 60. Top-down Approaches
Research Methodology:
Helicobacter Pylori Infection Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|